Tenet Healthcare Co. (NYSE:THC – Free Report) – Equities researchers at Zacks Research increased their Q2 2025 earnings per share estimates for shares of Tenet Healthcare in a report released on Wednesday, February 26th. Zacks Research analyst R. Department now forecasts that the company will earn $2.68 per share for the quarter, up from their prior estimate of $2.66. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q4 2025 earnings at $3.36 EPS and FY2025 earnings at $11.84 EPS.
Other research analysts also recently issued research reports about the stock. Wells Fargo & Company downgraded shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $205.00 to $150.00 in a report on Monday, November 25th. StockNews.com downgraded shares of Tenet Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday. Raymond James downgraded shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price target for the company. in a research note on Friday, November 22nd. TD Cowen assumed coverage on shares of Tenet Healthcare in a report on Wednesday, February 26th. They set a “buy” rating and a $175.00 price objective on the stock. Finally, Barclays cut their price objective on shares of Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating on the stock in a report on Thursday, February 13th. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Tenet Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $163.88.
Tenet Healthcare Trading Down 1.4 %
Shares of Tenet Healthcare stock opened at $122.77 on Monday. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. Tenet Healthcare has a twelve month low of $90.03 and a twelve month high of $171.20. The business has a 50-day moving average price of $132.79 and a 200-day moving average price of $146.53. The firm has a market cap of $11.68 billion, a price-to-earnings ratio of 3.81, a PEG ratio of 1.02 and a beta of 2.05.
Tenet Healthcare (NYSE:THC – Get Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, beating analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in THC. FMR LLC lifted its position in Tenet Healthcare by 88.0% during the third quarter. FMR LLC now owns 7,700,693 shares of the company’s stock valued at $1,279,855,000 after purchasing an additional 3,604,161 shares during the period. Norges Bank purchased a new stake in shares of Tenet Healthcare during the fourth quarter worth about $190,819,000. Wealthfront Advisers LLC purchased a new stake in Tenet Healthcare during the 4th quarter valued at about $69,059,000. Geode Capital Management LLC grew its stake in Tenet Healthcare by 23.6% during the 3rd quarter. Geode Capital Management LLC now owns 2,044,667 shares of the company’s stock valued at $339,893,000 after acquiring an additional 390,316 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in Tenet Healthcare during the 4th quarter valued at about $49,001,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
See Also
- Five stocks we like better than Tenet Healthcare
- Insider Trades May Not Tell You What You Think
- GitLab: Get In While It’s Down—Big Rebound Ahead
- What is the Shanghai Stock Exchange Composite Index?
- Tesla Stock: Finding a Bottom May Take Time
- Trading Halts Explained
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.